Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Equity Average: 2021-2025

Historic Equity Average for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $810.9 million.

  • Cellebrite DI's Equity Average fell 99.22% to $810.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $810.9 million, marking a year-over-year decrease of 99.22%. This contributed to the annual value of $185.1 million for FY2024, which is 980.79% up from last year.
  • According to the latest figures from Q3 2025, Cellebrite DI's Equity Average is $810.9 million, which was up 8.31% from $748.7 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Equity Average high stood at $104.1 billion for Q3 2024, and its period low was -$101.7 million during Q4 2021.
  • Over the past 3 years, Cellebrite DI's median Equity Average value was $482.6 million (recorded in 2024), while the average stood at $19.3 billion.
  • Its Equity Average has fluctuated over the past 5 years, first plummeted by 99.93% in 2022, then soared by 50,328.42% in 2024.
  • Quarterly analysis of 5 years shows Cellebrite DI's Equity Average stood at -$101.7 million in 2021, then soared by 165.57% to $66.7 million in 2022, then soared by 283.39% to $255.6 million in 2023, then surged by 88.84% to $482.6 million in 2024, then slumped by 99.22% to $810.9 million in 2025.
  • Its last three reported values are $810.9 million in Q3 2025, $748.7 million for Q2 2025, and $523.0 million during Q1 2025.